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The recent discovery that the activation domains of transcriptional activators (e.g., GAL4) from a number of 
species are interchangeable has led to the concept of a general mechanism for activation of RNA polymerase II
genes. We have examined the different activities of the SV40 octamer motif ATGCAAAG in B cells and in 
HeLa cells in the context of either the [3-globin promoter, a TATA-box-containing mRNA promoter, or the U2 
snRNA promoter, which contains a snRNA-specific proximal element. In the context of the ~-globin promoter, 
the octamer motif is a B-cell-specific enhancer element, whereas it is a ubiquitous enhancer element for the U2 
snRNA promoter. The U2 promoter is unique in that it is not activated by enhancer elements that activate the 
[3-globin promoter, and a hybrid U2 promoter containing the upstream activating sequence UASG is not 
stimulated by a yeast GAL4 trans-activator. Together, these observations suggest that in the context of the U2 
promoter, the octamer motif defines a new class of RNA polymerase II enhancer elements, which bind 
transcription factors that trans-activate gene expression by a different mechanism than the general mechanism 
mentioned above. These results are discussed in light of the possibility that the ubiquitous octamer binding 
protein Oct-1 and the B-cell-specific octamer binding protein Oct-2 are involved in the activation of the U2 and 
~-globin promoters, respectively. 
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Recent studies with yeast and mammalian transcrip- 
tional activators, such as GAL4, GCN4, and steroid re- 
ceptors, have revealed a general mechanism for activa- 
tion of RNA polymerase II transcription {for review, see 
Ptashne 1988}. These trans-activators contain a se- 
quence-specific DNA-binding domain {Brent and 
Ptashne 1985; Hope and Struhl 1986; Keegan et al. 1986} 
and a trans-activation domain often characterized by a 
high concentration of acidic residues (Ma and Ptashne 
1987a, b; Hope et al. 1988}. The specificity of transcrip- 
tional control is conferred by the DNA-binding domain, 
whereas the trans-activation domains of different rans- 
activators eem to be functionally equivalent and can be 
interchanged [Lech et al. 1988; Sadowski et al. 1988; 
Struhl 1988; Webster et al. 1988}. Thus, a trans-activator 
such as GAL4 can stimulate transcription from various 
RNA polymerase II promoters in cells from species as 
divergent as yeast, animals, and plants, provided that the 
promoter contains an appropriate DNA-binding site, in 
this case the GALl -GALl0 upstream activating se- 
quence UAS G {Fischer et al. 1988; Kakidani and Ptashne 
1988; Ma et al. 1988; Stmhl 1988; Webster et al. 1988}. 
Indeed, in mammalian cells the UASG has the properties 
tPresent address: Biocentre, University of Basel, Basel, Switzerland. 
of an enhancer in the presence of GAL4 {Webster et al. 
19881. 
A common mechanism for activation of transcription 
is consistent with results obtained from a genetic anal- 
ysis of the SV40 enhancer. These studies have shown 
that the SV40 enhancer contains at least three indepen- 
dent elements, called A, B, and C, which can compen- 
sate functionally for one another by duplication {Herr 
and Clarke 1986; Ondek et al. 1987; Schirm et al. 1987}. 
More recently, the SV40 A and B elements were shown 
to be bipartite, being composed of interchangeable sub- 
units called enhansons {for basic unit of enhancer struc- 
ture; Ondek et al. 1988}. The ability of different en- 
hancer elements to compensate functionally for one an- 
other suggested that the factors responsible for their 
function activate transcription through a common 
mechanism [Herr and Clarke 1986}. 
If the mechanism of transcription activation is gen- 
eral, however, the octamer motif presents a paradox. 
This motif is found in the promoter region of heavy- and 
light-chain immunoglobulin genes, in the heavy-chain 
(IgH) enhancer, and in the SV40 promoter (Falkner and 
Zachau 1984; Parslow et al. 1984; Falkner et al. 1986). In 
these promoters and when inserted upstream or down- 
stream of several other mRNA promoters, the octamer 
motif displays lymphoid-specific activity (Davidson et 
al. 1986; Gerster et al. 1987; Lenardo et al. 1987; Wirth 
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et al. 1987). But the octamer motif also plays a role in 
non-B cells as an enhancer of snRNA transcription 
(Mattaj et al. 1985; Mangin et al. 1986; Ares et al. 1987; 
for review, see Dahlberg and Lund 1988) and as a cell- 
cycle-regulated proximal element in the human histone 
H2B gene (Harvey et al. 1982; LaBella et al. 1988). These 
different patterns of lymphoid-specific and ubiquitous 
transcriptional regulation parallel the expression of two 
proteins that bind indistinguishably to the octamer 
motif (Landolfi et al. 1986; Staudt et al. 1986; Rosales et 
al. 1987; Scheidereit et al. 1987). One of these proteins is 
expressed predominantly in lymphoid cells of the B lin- 
eage, whereas expression of the second is ubiquitous 
(Landolfi et al. 1986; Singh et al. 1986; Staudt et al. 
1986; Rosales et al. 1987; Scheidereit et al. 1987; Sturm 
et al. 1988). The B-cell-specific octamer binding protein, 
NF-A2 (Staudt et al. 1986) or OTF-2 (Scheidereit et al. 
1987), is the product of the oct-2 gene and referred to 
here as Oct-2, whereas the ubiquitous octamer binding 
protein, variously referred to as NF-A1 (Staudt et al. 
1986), OTF-1 (Fletcher et al. 1987), NFIII (Pruijn et al. 
1986; O'Neill and Kelly 1988), and OBP100 (Sturm et al. 
1987), is the product of the oct-1 gene and referred to 
here as Oct-1 (see Clerc et al. 1988; Sturm et al. 1988). 
The differential expression of Oct-2 and Oct-l, however, 
does not explain how these factors discriminate in acti- 
vating different promoters. If trans-activation domains 
are interchangeable, why are the immunoglobulin pro- 
moters not trans-activated, as are snRNA promoters, by 
the ubiquitous octamer binding factor in nonlymphoid 
cells? The answer may lie, in part, in the structure of the 
snRNA promoters. 
The U1 and U2 snRNA genes encode short, nonpolya- 
denylated RNAs that are involved in pre-mRNA 
splicing. In addition to being very highly transcribed by 
RNA polymerase II (Frederiksen et al. 1978; Gram 
Jensen et al. 1979; Murphy et al. 1982), these genes hare 
a number of unusual characteristics when compared to 
mRNA-encoding genes. First, the promoters lack a 
TATA box and instead contain a snRNA-specific prox- 
imal element located 40-60 bp upstream of the tran- 
scriptional start site (Skuzeski et al. 1984; Ares et al. 
1985; Ciliberto et al. 1985; Mattaj et al. 1985; Mangin et 
al. 1986; Murphy et al. 1987; Hernandez and Lucito 
1988). Second, 3' end formation of snRNAs occurs by an 
unusual mechanism that requires a signal, called the 3' 
box, located downstream of the snRNA-coding region 
(Hemandez 1985; Yuo et al. 1985; Ciliberto et al. 1986; 
Neuman de Vegvar et al. 1986; Ach and Weiner 1987). 
Although necessary, the 3' box is not sufficient for cor- 
rect U1 or U2 3' end formation, because if the promoter 
regions of these genes are replaced by promoters that di- 
rect transcription of mRNAs (e.g., [3-globin or adeno- 
virus major late promoters), the 3' box is ignored and 
mature RNAs extend to a polyadenylation site inserted 
downstream (Hemandez and Weiner 1986; Neuman de 
Vegvar et al. 1986). Moreover, even with a fully func- 
tional U2 promoter, only correctly initiated transcripts 
terminate properly. Transcripts that initiate at cryptic 
promoters upstream in the vector and read through the 
U2 gene ignore the 3' box and become polyadenylated 
(Hemandez and Lucito 1988). Extensive mutagenesis of
the U2 promoter region has shown that multiple U2 pro- 
moter elements, including the enhancer, are involved in 
directing an RNA polymerase II transcription complex 
that can recognize the 3' box (Hernandez and Lucito 
1988). 
Although it has been known for some time that en- 
hancer elements containing the octamer motif lie up- 
stream of snRNA promoters (Mattaj et al. 1985; Mangin 
et al. 1986; Murphy et al. 1987}, it is not clear whether 
these enhancers are dedicated specifically to snRNA 
transcription. Experiments in which the Xenopus (Cili- 
berto et al. 1987} or human (Dahlberg and Schenborn 
1988) U1 enhancers were placed upstream of the SV40 
early promoter suggest that the U1 enhancer cannot ac-
tivate transcription from mRNA-encoding enes. It has 
been reported, however, that the SV40 enhancer can ac- 
tivate U2 transcription (Mangin et al. 1986), although in 
some constructs, insertion of the SV40 enhancer region 
also resulted in activation of aberrantly initiated tran- 
scripts (Hernandez and Weiner 1986). The SV40 en- 
hancer contains multiple redundant elements {Herr and 
Clarke 1986; Zenke et al. 1986), as well as two octamer- 
related motifs (Falkner and Zachau 1984; Sturm et al. 
1987); therefore, it is not evident which of the SV40 en- 
hancer elements or octamer motifs was responsible for 
specific U2 transcriptional ctivation. 
To understand the nature of the lymphoid-specific and 
ubiquitous enhancer activities of the octamer motif, we 
have studied the ability of different versions of the SV40 
B element o enhance xpression of the human [3-globin 
and U2 snRNA promoters in HeLa cells and B cells. The 
B element contains a tandemly repeated 9-bp sph motif 
and a 7- out of 8-bp match to the octamer consensus 
formed by the junction of the two sph motifs (see Fig. 
1A). In HeLa cells, the ability of the B element o en- 
hance 13-globin expression is dependent on the sph 
motifs, whereas the octamer motif is inactive (Davidson 
et al. 1986; Zenke et al. 1986; Ondek et al. 1987, 1988). 
Here, we introduce sets of point mutations into the B 
element that suppress ph motif or octamer motif func- 
tion independently or together. Functional tests of mul- 
timerized wild-type and mutant B elements how that 
the sph motifs and the SV40 A and C enhancer elements 
are unable to activate the U2 promoter. In contrast, the 
octamer motif, which in the context of the [3-globin pro- 
moter is a B-cell-specific enhancer element, can enhance 
the U2 snRNA promoter in either B cells or HeLa cells. 
Nevertheless, the ~-globin promoter can be activated by 
the octamer motif in HeLa cells if the herpes simplex 
virus (HSV) gene product VP16 is present. These pat- 
terns of activity suggest that the lymphoid octamer 
binding protein and the ubiquitous octamer binding pro- 
tein in the presence of VP16 can activate transcription 
by a mechanism analogous to that used by the GAL4 
acidic trans-activating domain. These results also sug- 
gest that in contrast, the ubiquitous octamer binding 
protein stimulates transcription of snRNA genes by a 
different mechanism. Consistent with this hypothesis, 
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we show that a GAL4 trans-activator capable of acti- 
vating the [3-globin promoter does not activate the U2 
promoter. 
Resu l ts  
Figure 1A shows the position of the three SV40 enhancer 
elements A, B, and C, with respect to the SV40 early 
promoter. It also shows the sequence of the B-element 
region along with the position of the two sph motifs 
(sphlI and sphI) and the 7- out of 8-bp match {ATG- 
CAAAG) to the octamer consensus sequence {ATG- 
CAAAT). Despite the single base difference with the 
consensus octamer motif, the SV40 octamer motif is in- 
volved in activation of transcription in B cells {Davidson 
et al. 19861 and binds to both the lymphoid and ubiqui- 
tous octamer binding factors (Rosales et al. 1987}. In ad- 
dition, we have shown that Octol (OBP100) binds with 
only slightly reduced affinity to this SV40 octamer 
Figure 1. (AI The first line shows the SV40 early promoter re- 
gion with a single copy of the 72-bp element, two perfect and 
one imperfect 21-bp repeats, the AT-rich TATA-like element, 
the origin of replication (ori), and the early transcriptional start 
sites (wavy arrow). Below, the locations of the three SV40 en- 
hancer elements A, B, and C are indicated. The third line shows 
the sequence of the B element region; the sph motifs are under- 
lined, and the octamer motif at the junction of the two sph 
motifs is bracketed. (B) Sequence of the wild-type and mutant 
B20 synthetic enhancer repeats. When the B20 oligonucleotides 
are reiterated, the boxed nucleotides constitute XhoI restriction 
sites. The changes introduced by the double point mutations 
dpm2, dpm7, and dpm8 are indicated. (C) Structure of the IB- 
globin and U2 expression vectors. The plasmid pBe- is as de- 
scribed previously (Ondek et al. 19871 and contains the human 
B-globin gene (stippled box) inserted into the polylinker 
(hatching) of pUC119 (thin line). The B-globin transcriptional 
start site is depicted by a wavy arrow. The synthetic enhancers 
consist of six wild-type or mutant B20 repeats (arrows) sepa- 
rated by XhoI restriction sites (boxes), and were inserted either 
into the Sinai restriction site, 143 bp upstream of the [3-globin 
transcriptional start site in the + orientation, or into the SphI 
restriction site, 2.2 kb downstream (or 3.3 kb upstreaml of the 
start site in the ( - ) orientation. The plasmid pU2/- 198 (Her- 
nandez and Lucito 1988) contains a hybrid U2 gene inserted 
between the EcoRI and HindIII sites of pUC13 (thin linel. The 
hybrid gene consists of (1) a human U2 promoter (thick black 
box) deleted to position -198 upstream of the cap site and 
therefore lacking the U2 enhancer, (2) the first 28 bp of the U2- 
coding region (open box), (3) a 137-bp fragment derived from the 
rabbit B-globin gene and cloned in the reverse orientation (wavy 
line), (4) the last 6 bp of the Ul-coding region (arrowhead), (5) 90 
bp of U1 3'-flanking sequences (thin black box) containing the 
3' box. This is followed by a fragment derived from adenovirus 
2 and carrying the L3 polyadenylation site (white box) and a 
fragment carrying the SV40 origin of replication (hatched box). 
The U2 transcriptional start site is depicted by a wavy arrow. 
The synthetic enhancers were inserted at position -198, up- 
stream of the transcriptional start site in the + orientation. (D) 
Structure of the human U2 promoter. The locations of the en- 
hancer, which contains an Spl-binding site (SP1) adjacent to an 
octamer motif (OCTA), as well as the proximal element (PEI are 
indicated. 
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motif, compared to the perfect histone H2B octamer 
motif [Baummker et al. 1988}. These results and those 
described below indicate that this SV40 octamer-related 
motif is a bona fide octamer element. The activity of a 
second, more degenerate, octamer motif (ATCTCAATI, 
which flanks the first octamer motif and is also a 
binding site for Oct-1 {Sturm et al. 1987; Baumruker et 
al. 19881, has not been analyzed in these studies. 
Figure 1B shows the structure of the wild-type and 
mutant  24-bp oligonucleotide repeats that we used to 
study the activities of the octamer motif and overlap- 
ping sph motifs. Each oligonucleotide repeat contains 18 
bp of the wild-type or mutant SV40 sequence separated 
by 6-bp XhoI recognition sites. Fortuitously, the AG di- 
nucleotide of the XhoI recognition sequence CTCGAG 
extends the wild-type SV40 enhancer sequence by 2 bp. 
We therefore refer to these elements as B20. As shown 
below and described previously [Ondek et al. 1987), the 
AG dinucleotide sequence is not essential for the ac- 
tivity of the B element. The three sets of double point 
SV40 
1 
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mutations {dpm) shown in Figure 1B were designed to 
discriminate between the activities of the sph motifs 
and the octamer motif. The dpm2 mutation lies within 
the sphI motif and nullifies the ability of oligomerized B 
element constructs to enhance transcription of the 6- 
globin gene in HeLa cells (Ondek et al. 1987, 1988} but 
does not affect binding of Oct-1 to the octamer motif 
(Sturm et al. 1987). The dpm7 mutation was designed to 
inactivate the octamer motif but not affect the activity 
of the sph motifs; we used as a guide a similar mutation 
(pA24; Zenke et al. 1986), which affects expression of 
the SV40 promoter more in B cells than in HeLa cells 
(Davidson et al. 1986). The dpm7 mutation hinders, but 
does not abolish, Oct-1 binding to the octamer motif in a 
gel retardation assay (R. Sturm and T. Baumruker, un- 
publ.). The dpm8 mutation lies within the sphII motif 
and is analogous to the dpm2 mutation within the sphI 
motif. But unlike dpm2, this mutation interferes 
strongly with Oct-1 binding to the B element octamer 
motif (Sturm et al. 1987) and inactivates the B element 
under all conditions assayed (see below). Thus, in the 
studies described below, the wild-type element displays 
both sph and octamer motif activities, the dpm2 and 
dpm7 mutants display octamer and sph motif activity, 
respectively, whereas the dpm8 mutant is inactive. 
To test the enhancer {distal) and upstream promoter 
(proximal) activities of this set of four elements in the 
context of an mRNA-encoding ene, six tandem copies 
were inserted into the human B-globin expression vector 
pBe-, 2.2 kb downstream and also 143 bp upstream of 
the B-globin transcriptional start site (see Fig. 1C). To 
test snRNA promoter activation, the same set of tandem 
elements were cloned 198 bp upstream of the U2 tran- 
scriptional start site in the human U2 expression vector 
pU2/-198, replacing the U2 enhancer element, which 
itself contains juxtaposed binding sites for octamer and 
Spl-like factors (Mangin et al. 1986; Ares et al. 1987; 
Janson et al. 1987), as indicated in Figure 1D. The ac- 
tivity of the various constructs was assayed by transient 
expression in HeLa cells and NS-1 cells, the latter of 
which are nonimmunoglobulin-secreting murine B cells. 
Levels of promoter activation were gauged by RNase 
protection of antisense RNA probes and normalization 
to expression of a cotransfected human ~-globin gene, 
which served as an internal reference for transfection ef- 
ficiency. Below we first describe the ability of the dif- 
ferent oligomerized lements to activate the ~-globin 
gene in the NS-1 B cell line and then compare the ability 
of these constructs to activate the [3-globin and U2 pro- 
moters in HeLa cells. 
The SV40 octamer (decamer) motif is sufficient o 
enhance transcription of the fl-globin gene in B ceils 
Figure 2 shows the result of transient expression in the 
NS-1 B cell line of fbglobin constructs containing the 
matched set of B elements. The reference c~-globin-pro- 
tected fragment (labeled cx) is 132 nucleotides long and 
maps the 5' end of the a-globin RNA. Correctly initiated 
B-globin transcripts protect a 350-nucleotide-long frag- 
RNA polymerase II trans-activation 
Figure 2. Activation of the B-globin promoter in NS-1 B cells. 
p[3e- derivatives were transfected into NS-1 B cells, together 
with the plasmid ~rSVHPa2 {Treisman et al. 1983) as an in- 
ternal reference. Cytoplasmic RNA was analyzed by RNase 
protection mapping using a mixture of two probes, one map- 
ping transcripts derived from the [3-globin gene {[3350 probe) and 
the other mapping transcripts derived from the ~-globin refer- 
ence gene (a132 probe). Bands corresponding to correctly initi- 
ated ~-globin ([3}and ~-globin {c~} transcripts are indicated. The 
B-globin constructs used in the transfection were pBenh- {lanes 
1 and 7), pB6×B20+/- 143 {lane 2), p~6×B2Odpm2+/- 143
{lane 31, pf36xBZOdpm7 +/-143 (lane 4), pB6×B2Odpm8+/- 
143 (lane 5), pBlx 72+/- 143 (lane 6), pB6xB20- (lane 8), 
p[36xB20dpm2- (lane 9), p~6xB20dpm7- (lane 10), 
pB6 x B2Odpm8- (lane 11 }, p~l x 72- (lane 12), and pI3Igh- (lane 
13), a pf~e- derivative containing the mouse IgH enhancer in- 
serted downstream of the transcriptional start site. The struc- 
tures of the different constructs are indicated above the lanes. 
The 6 x B2Odpm2 construct is active in B cells, in contrast o 
the 6xB17dpm2 construct described previously {Ondek et al. 
1987). The lack of octamer motif activity in the 6 x B17dpm2 
construct in B ceils is a peculiarity of this particular synthetic 
enhancer. 
ment (labeled [3) from RNase digestion. In this assay, 13- 
globin transcripts that initiate upstream of the correct 
start site generally appear as a slightly shorter fragment 
because of splicing to a cryptic splice acceptor 30 nu- 
cleotides downstream of the bona fide ~-globin tran- 
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Table 1. Relative activation of fl-globin or U2 expression by wild-type and mutant  6 x B20 repeats 
~-globin" ~-globin" U2 b 
6 x B20 NS- 1 B cells HeLa HeLa 
enhancer upstream downstream upstream downstream readthrough U2 5' 
B-globin c
HeLa + VP16 
upstream downstream 
Wild type 1 0.08 1 0.5 1 1 1.2 N.D. a 
dpm2 2.30 0.13 0.07 0.04 0.2 2.3 0.8 0.07 
dpm7 0.04 0.01 1.4 0.7 1.5 0.1 1.1 N.D. 
dpm 8 0.01 0.01 0.04 0.04 0.09 0.01 0.04 N.D. 
None 0.01 0.01 0.05 0.05 0.15 0.01 0.06 0.06 
"Levels of expression are the average of two transfections and were within - 20%. The [3-globin results are normalized to the wild- 
type 6 x B20 upstream construct for both NS-1 and HeLa cells. 
b The U2 transcription levels are normalized to the wild-type construct in each case. 
c The VP16 trans-activation results are normalized to the upstream 6 x B20 wild-type HeLa cell sample without VP16. 
d (N.D.) Not determined. 
scriptional start site (de Villiers and Schaffner 1981; see 
the extra band in lanes 8, 9, and 13 in Fig. 2). In each 
experiment, fbglobin constructs lacking an enhancer or 
wi th one repeat of the wild-type SV40 enhancer (1 x 72) 
were transfected for comparison. To quantitate relative 
levels of fPglobin expression, the radioactivity present in 
each band was measured and normalized to the level of 
a-globin expression. Table 1 summarizes the quantita- 
tive results for the various assays described in this paper. 
Both of the constructs with wild-type SV40 octamer 
motifs (wt and dpm2)  activated [3-globin gene expression 
in B cells, albeit 12-fold more efficiently close to the 
transcriptional start site (upstream) than at the distal 
posit ion 2.2 kb downstream (Fig. 2, cf. lanes 2 and 3 with 
lanes 8 and 9; see Table 1). In contrast, the octamer 
moti f  mutants  were nearly (dpm 7) or completely (dpm8)  
inactive in either posit ion (Fig. 2, lanes 4, 5, 10, and 11). 
These results are consistent with previous reports. 
Schirm et al. (1987) and Ondek et al. (1987) showed that 
similar segments of the SV40 enhancer were active as 
enhancers in B cells, and Davidson et al. (1986) showed 
that in its natural context, mutat ions with in the oc- 
tamer moti f  affected B-cell function of the SV40 early 
promoter. 
However, these previous tudies did not address 
whether the octamer moti f  can activate transcription i  
B cells autonomously  or whether it is part of a bipartite 
element, requiring additional f lanking sequences. In- 
deed, the B cell-specific activity of the SV40 octamer 
moti f  could be conferred by an adjacent B cell-specific 
enhancer. To test this possibility, we assayed the ~- 
globin enhancer (distal) activity of a large number  of 
mutants  of the B20 repeat in both NS-1 and HeLa cells. 
As shown in Table 2, except for one particular case 
(dpm4) in which enhancer activity was partial ly abol- 
ished, only mutat ions with in the octamer motif  i tse l f - -  
dpm7,  dpm8,  and dpml l - -a f fec ted  B cell enhancer 
function, and these all abolished activity. These results 
suggest hat the activity of the SV40 B-element region in 
B cells rests with the octamer moti f  alone. Therefore, 
the octamer motif  is an example of an enhanson that can 
enhance transcription independently of an immediately 
adjacent enhanson. It may be significant hat as a soli- 
tary enhanson the octamer moti f  displays considerably 
more activity when posit ioned in a promoter proximal 
position, whereas the sph enhansons, which work as a 
pair (Ondek et al. 1988), are relatively unaffected by dis- 
tance in this assay (see Table 1). 
Table 2. Effect of mult ip le point mutat ions within the B20 repeat on downstream activation of fl-globin expression 
6 x B20 Octamer NS-1 
enhancer GAGAAGT [ ATGCAAAG l CATGCACTC B cells" HeLa" 
Wild type . . . . . . . . . . . . . . . . . . . . . . . .  + 
dpm2 . . . . . . . . . . . . . . . . .  A .  G . . . .  + 
dpml6  . . . . . . . . . . . . . . . . .  G . A . . . .  + 
dpm4 . . . . . . . . . . . . . . . . .  C .  T . . . .  + / -  
dpm7 . . . . . . . . .  TT . . . . . . . . . . . . .  - 
dpm8 . . . . . . . .  A . G . . . . . . . . . . . . .  - 
dpml  l . . . . . . . .  C .  T . . . . . . . . . . . . .  - 
sphI/sphI . . . . . .  C . . . . . . . . . . . . . . . . .  + 
sphII/sphII . . . . . . . . . . . . . . .  T . . . . . . . .  + 
dpml3  . GC . . . . . . . . . . . . . . . . . . . . .  + 
dpm2/13 . GC . . . . . . . . . . . . . .  A. G . . . .  + 
dpm2/17 . . . TT . . . . . . . . . . . .  A. G . . . .  + 
None 
+ 
+/ -  
+ 
+ 
+ 
* ( + ) 80-160% ; ( + / - ) 30%; ( - ) < 12% the level of wild-type 6 x B20 expression. 
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The octamer motif activates the U2 promoter but not 
the fl-globin promoter in HeLa cells 
Figure 3 shows a comparison of the activity in HeLa 
cells of the wild-type and mutant oligomerized SV40 B 
element constructs when positioned upstream or down- 
stream of the ~-globin gene and when replacing the 
natural U2 enhancer. As in NS-1 cells, the wild-type 
6 x B20 construct activates f~-globin expression in HeLa 
cells (Fig. 3A, lanes 2 and 8), whereas the dpm8 mutant 
fails to enhance ~-globin expression (lanes 5 and 11). 
However, in clear contrast o the results in NS-1 cells, 
the dpm2 mutant with a wild-type octamer sequence 
displays no activity in HeLa cells, either proximal or 
distal to the ~-globin promoter (lanes 3 and 9). Moreover, 
the octamer mutant dpm7, which is inactive in B cells, 
is completely active in HeLa cells (lanes 4 and 10). This 
result shows succinctly that the activity of the short 
20-bp B-element sequence in NS-1 and HeLa cells is the 
result of two separable but overlapping cis-acting ele- 
ments. 
Figure 3B shows the relative activity of the oligomer- 
ized B element constructs in the context of the U2 pro- 
moter. An important aspect of the U2 expression assay 
is that we monitor two transcriptional ctivities simul- 
taneously-correctly initiated transcripts derived from 
the U2 promoter (U2 5') and readthrough transcripts de- 
rived from cryptic promoters located upstream of the 
correct start site (readthrough). These two types of tran- 
scripts are qualitatively different because only tran- 
scripts that initiate at the correct U2 start site terminate 
at the downstream 3' box (see Fig. 1C); the readthrough 
transcripts are 'mRNA-like' in that they continue to the 
downstream adenovirus L3 polyadenylation site (see Fig. 
1C; Hernandez and Lucito 1988). Thus, these two tran- 
scripts are the result of distinctly different transcrip- 
tional complexes and, as shown here, respond ifferently 
to the multimerized enhancer elements. 
Consistent with its broad activity, the wild-type B ele- 
ment (Fig. 3B, lane 2) activates both the correctly initi- 
ated U2 transcripts and the readthrough transcripts, 
whereas the dpm8 enhancer activates neither transcript 
(lane 5) and thus resembles the enhancerless U2 control 
template (lane 1). Activation of the U2 promoter by the 
wild-type B-element oligomer shows a subtle but im- 
portant difference compared with the wild-type U2 en- 
hancer control (lane 6): The ratio of readthrough to cor- 
rectly initiated U2 transcripts i  > 10-fold higher in the 
6 x B20 construction. This difference is accentuated all 
the more dramatically by the activity of the dpm2 and 
dpm7 mutants. The dpm2 construct, which contains a 
wild-type octamer motif and does not enhance f~-globin 
expression effectively in HeLa cells, enhances correctly 
initiated U2 transcripts but not readthrough transcripts 
(lane 3) in these cells. In contrast, the dpm7 mutant, 
which does activate ~-globin expression, only weakly 
activates correctly initiated U2 RNAs but strongly acti- 
vates the readthrough transcripts (lane 4). The activities 
of the U2 constructs in B cells are similar to those ob- 
served in HeLa cells, except that the stimulation is 
RNA polymerase II trans-activation 
weaker (data not shown). To ensure that the different 
activities of the B element on the U2 and f~-globin pro- 
moters were not due to differences in the expression 
vectors, we transferred the ~-globin promoter with the 
synthetic enhancers at position -143 into the U2 ex- 
pression vector, replacing only the U2 promoter se- 
quences. The results obtained with these constructs 
were similar to those described above for the pf~ con- 
structs. The activities of the B element oligomers are 
summarized in Figure 3C. 
To show that the inability of 6xB2Odpm7 to enhance 
expression of the U2 promoter efficiently is a general 
property of enhancer elements that can activate ~-globin 
expression, we assayed the activity of the SV40 A and C 
enhancer elements in the U2 expression vector. As 
shown in Figure 3B, these enhancers fail to activate the 
U2 promoter at all (cf. lanes 8 and 9 with lane 11). In 
comparison, a different synthetic enhancer (6xB17), 
which contains the octamer motifs spaced differently, 
still activates U2 transcription (lane 10). The 6xB17 
synthetic enhancer also activated U2 transcription when 
inserted ownstream of the gene, although much less ef- 
ficiently (not shown). Thus, the octamer motif is clearly 
unique in its ability to activate the U2 promoter and in- 
ability to activate the f~-globin or U2 readthrough tran- 
scripts in HeLa cells. 
A GAL4 acidic domain does not activate the U2 
promoter 
Recent studies have shown that the yeast rans-activator 
GAL4 can activate the MMTV (Kakidani and Ptashne 
1988), HSV-1 thymidine kinase, rabbit ~-globin, and 
adenovirus major late promoters (Webster et al. 1988) in 
mammalian cells, provided GAL4 DNA-binding sites 
are inserted into the test promoter constructs. A GAL4 
mutant that retains the DNA-binding domain (the 
amino-terminal 147 amino acids) but lacks the se- 
quences required for transcriptional ctivation in yeast 
does not activate transcription i  mammalian cells (Ka- 
kidani and Ptashne 1988). Either of two separable trans- 
activation domains of GAL4 (called I and II), both of 
which are characterized by a high concentration of 
acidic residues (Ma and Ptashne 1987a), can enhance 
transcription i mammalian cells (Kakidani and Ptashne 
1988). Thus, these acidic domains can indiscriminately 
activate a variety of TATA-box-containing mRNA pro- 
moters. Because mammalian enhancer elements are un- 
able to activate the U2 promoter, we asked whether a 
functional GAL4 trans-activator would also be incapable 
of activating U2 transcription. 
The GAL4 upstream activating sequence (UASG) was 
cloned upstream of the human ~-globin and U2 pro- 
moters (see Fig. 1C), and expression of ~-globin and U2 
reporter transcripts was assayed in the presence or ab- 
sence of the functional GAL4 deletion mutant GAL4 
(1 - 147, 768-881), expressed by the plasmid pAG236, or 
the nonfunctional mutant GAL4(1-147), expressed by 
pAG147 (Kakidani and Ptashne 1988). The functional 
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RNA polymerase II trans-activation 
GAL4 derivative contains activation domain II fused to 
the DNA-binding domain, whereas GAL4(1-147) re- 
tains the DNA-binding domain but lacks both activation 
domains I and II. Figure 4 shows the results of one such 
experiment in HeLa cells. Consistent with previous 
studies (Kakidani and Ptashne 1988), cotransfection of 
pAG236 does not activate the human f~-globin promoter 
in the absence of a GAL4-binding site (cf. lanes 1 and 2). 
Unexpectedly, simple insertion of the UASc element 
upstream of the f~-globin promoter slightly reduced ex- 
pression from this promoter (cf. lanes 1 and 3). However, 
as expected, cotransfection of the GAL4(1-147) DNA- 
binding domain had no discernible ffect on expression 
(lane 4), whereas the functional GAL4 activator stimu- 
lated f~-globin expression (lane 5). 
In contrast, stimulation of transcription from a U2 
promoter containing the UASG could not be observed in 
the presence of the functional GAL4 activator (Fig. 4, cf. 
lanes 9 and 10; even on very long exposures of these pro- 
tection assays in which the residual evel of enhancer- 
less transcription could be detected, there was no evi- 
dent stimulation by the GAL4 activator). Significantly, 
although the correctly initiated U2 transcripts were not 
activated, the readthrough transcripts that are stimu- 
lated by the SV40-derived enhancer elements were also 
enhanced by the GAL4 activator (lane 10) but not by the 
GAL4 DNA-binding domain alone (lane 9). This result 
serves as an important control showing that the GAL4 
activator was functional in this assay. To show that the 
lack of U2 stimulation was not an artifactual UASG po-  
sition effect, U2 expression was lso assayed with the 
UASG positioned immediately upstream of the U2 prox- 
imal element (at -62); this construct also failed to be 
activated by the GAL4 activator (data not shown). Acti- 
vation of the U2 and [3-globin UASc constructs by GAL4 
was also tested in B cells, with similar results as those 
described above (not shown). Because the GAL4 acti- 
vator does not activate the U2 promoter, which is tran- 
scribed by RNA polymerase II, we conclude that the 
GAL4 activator is not a universal RNA polymerase II
activator. 
The octamer motif  can activate the [3-globin promoter 
from a proximal but not distal position in the presence 
of the HSV trans-activator VP16 in HeLa cells 
The HSV-encoded late gene product VP16 (Vmw65) is a 
trans-activator of the HSV immediate arly (IE) region 
genes {Campbell et al. 1984). This trans-activator is 
packaged into the virion and, upon infection of the host 
cell, trans-activates the HSV IE genes not through direct 
DNA binding (Marsden et al. 1987} but, rather, through 
interaction with cellular intermediates (Kristie and 
Roizman 1987; McKnight et al. 1987; O'Hare and 
Goding 1988; Preston et al. 1988; Tnezenberg et al. 
1988b). The domain within VP16 that is responsible for 
trans-activation is highly negatively charged and thus is 
an excellent example of an acidic trans-activation do- 
main (Triezenberg et al. 1988a). VP16 can activate HSV 
IE gene expression through different sequence motifs, 
cK 
oa ~ 
t-~ + + 
2 3 4  5 
Figure 4. Trans-activation properties of GAL4 on the [3-globin 
and U2 promoters. [Left) p[3enh- (lanes 1 and 2) and p[3UASJ 
-143 (lanes 3-5), a p[3e- derivative with the UAS G inserted 
143 bp upstream of the transcriptional start site, were trans- 
fected into HeLa cells, with or without a second plasmid ex- 
pressing the DNA-binding domain of GAL4 (pAG147) or the 
DNA-binding domain a d trans-activation domain II of GAL4 
{pAG236) (Kakidani and Ptashne 1988}. arSVHPot2 was included 
in each transfection as an internal reference. Cytoplasmic RNA 
was analyzed by RNase protection mapping with the [3350 and 
(x132 probes. Bands corresponding to correctly initiated [3- 
globin ([3) and cx-globin {or) RNA are indicated. {Right) 
pU2/-198 [lanes 6 and 7) and pU2UASG/--198, a pU2/-198 
derivative with the UASG inserted 198 bp upstream of the tran- 
scriptional start site {lanes 8-10), were transfected into HeLa 
cells, with or without a second plasmid expressing the GAL4 
protein derivatives described above, as indicated above the 
lanes. [Lane 11) pU2/- 247 carrying the wild-type U2 promoter 
was used for transfection. The plasmid ~rSVHP~2 was included 
in each transfection as an internal reference. Cytoplasmic RNA 
was analyzed by RNase protection mapping with the U2 A 
probe and the (x98 probe. Bands corresponding to correctly initi- 
ated U2 (U2 5') and c~-globin (c~) transcripts are indicated. Bands 
corresponding to readthrough RNAs initiated at cryptic pro- 
moters within the vectors are labeled as such. T e upper right 
portion, showing the readthrough transcripts, is from a long ex- 
posure of the same gel shown below. 
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one of which includes the TAATGARAT motif (Kristie 
and Roizman 1984; Preston et al. 1984; Triezenberg et 
al. 1988b). The TAATGARAT motif is frequently asso- 
ciated with overlapping octamer motifs (Pruijn et al. 
1986; Gerster and Roeder 1988; O'Hare and Goding 
1988). Moreover, although considerably diverged in se- 
quence from the octamer motif, the TAATGARAT 
motif itself can bind directly to the HeLa cell octamer 
binding protein Oct-1 (OBP100) (Baumruker et al. 1988), 
and VP16 can trans-activate promoters containing the" 
octamer motif (O'Hare and Goding 1988). Therefore, we 
tested whether coexpression of VP16 could activate the 
otherwise inactive 8-globin expression construct 
6 x B2Odpm2, containing the wild-type octamer motif. 
Figure 5 shows the result of this experiment. Except 
upst ream downst ream 
6x  B20 6xB20 
04 I"-.- (30 O,J 
',-- E E E E 
• "- 0 .  O .  0.. O .  
~ I F  I I 
'VPt6  - + - ÷ - 
I I  I I  I I  I [ - - ' -1 
+ - -  + - -  + - -  + 
o< - -  
. . . .  
i 2 3 4 5 6 7 8 9 fo i r 12 13 
HeLo 
Figure 5. Activation of the [3-globin promoter by the octamer 
motif in the presence of the VP16 protein in HeLa cells, pJ3e- 
derivatives were transfected into HeLa cells, either with (lanes 
labeled +) or without (lanes labeled -) the plasmid 
pMSVP16A1D3 (Triesenberg et al. 1988a), which directs ex- 
pression of the HSV trans-activator VP16. The [3-globin con- 
structs used in the transfections are identical to those used in 
Fig. 2 and their structure is indicated above the lanes. (Lane 13) 
p[31 x 72- was used for comparison. The plasmid arSVHS~2 
(Treisman et al. 1983), which differs from ~rSVHP~2 by the ab- 
sence of the SV40 enhancer, was included in each transfection 
as an internal reference. Cytoplasmic RNA was analyzed by 
RNase protection mapping with the 6350 and cd32 probes. 
Bands are labeled as in Fig. 2. 
for the normally inactive dpm2 mutant, coexpression of
VP16 did not change the activities of the different [3- 
globin constructs. In contrast, the 6xB2Odpm2 con- 
struct is activated >10-fold by coexpression of VP16 (cf. 
lanes 5 and 6; see Table 1). Curiously, this activation is 
position dependent, because when the 6xB2Odpm2 
oligomers are positioned 2.2 kb downstream of the 8- 
globin promoter (see Fig. 1C), VP16 expression has little 
or no effect on 8-globin expression (cf. lanes 11 and 12; 
Table 1). Thus, the acidic trans-activation domain of 
VP16 can apparently convert an otherwise inactive oc- 
tamer motif into a 8-globin activator element but is not 
sufficient to confer enhancer function ver large dis- 
tances (see Discussion). 
Discussion 
We made use of the SV40 B element o elucidate how a 
single cis-acting element, the octamer motif, can acti- 
vate both cell-specific genes and ubiquitously expressed 
genes. The B element proved ideal to address this ques- 
tion, because it contains overlapping sph and octamer 
motifs, and the activities associated with these two 
types of motifs can be defined and separated by different 
sets of double point mutations. Thus, we could design a 
set of four matched wild-type and mutant oligomerized 
B-element constructs with either both, one, or none of 
the octamer and sph motif activities. This provided a 
built-in internal control, because for each promoter and 
cell line combination, at least one of the B element con- 
structs activated xpression. Thus, any observed failure 
of the B element o activate expression was a direct con- 
sequence of the specific point mutations and not the re- 
sult of a more general context effect. 
In summary, our results show that the sph motifs can 
activate the 8-globin promoter in HeLa cells, but these 
motifs, along with other SV40 enhancer elements, 
cannot activate the U2 promoter. In contrast, the oc- 
tamer motif can activate the U2 promoter in HeLa cells 
(and B cells) but can activate the 8-globin promoter only 
in B cells or only if the VP16 trans-activator is present in 
HeLa cells. Although our experiments do not identify 
directly the trans-acting factors responsible for these 
different activities, the correlation between the expres- 
sion patterns of the ubiquitous Oct-1 octamer binding 
protein (see Sturm et al. 1988) and the lymphoid-specific 
Oct-2 octamer binding protein (see Clerc et al. 1988) 
suggests that these two factors are, respectively, respon- 
sible for the ubiquitous snRNA activation and the B 
cell-specific 8-globin activation by the octamer motif. 
A model for octamer motif function in different 
promoters and cell types 
The different patterns of transcriptional ctivation by 
the octamer motif within the SV40 enhancer B element 
suggest the model presented in Figure 6. This figure 
shows a series of cartoons depicting hypothetical tran- 
scription complexes that form in B cells or HeLa cells, on 
either the 8-globin or U2 snRNA promoter carrying the 
SV40 B element. For simplicity, only one copy of the 
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RNA po lymerase II trans-activation 
SV40 B element is shown, and the RNA polymerase II 
complex itself is not represented. The pattern of U1 and 
U2 transcription sensitivity to a-amanit in demonstrates 
that these genes are transcribed by an RNA polymerase 
containing the large subunit of RNA polymerase II (Fre- 
deriksen et al. 1978; Gram Jensen et al. 1979). It should 
be noted, however, that the RNA polymerase II complex 
that transcribes nRNA genes may differ slightly from 
the RNA polymerase II that transcribes mRNA-en- 
coding genes. For example, it may lack an elongation 
factor (Hernandez and Lucito 1988). 
Figure 6A shows the transcription complex formed on 
the 6-globin promoter in B cells. A TATA box complex 
is shown bound close to the cap site, and the B cell-spe- 
cific Oct-2 factor is bound to the B element. This factor 
activates expression of mRNA genes and may therefore 
be a trans-activator of the GAL4 class. For this reason, 
the trans-activation domain of Oct-2 is shown nega- 
tively charged. Oct-2 is also shown interacting directly 
with the TATA complex because recent evidence sug- 
gests that in vitro, GAL4 can interact with the mamma- 
lian TATA factor TFIID on a promoter containing a 
GAL4-binding site inserted upstream of the TATA box 
(Horikoshi et al. 1988). The inactivity of the sph motifs 
in B cells suggests that the sph transcription factor is 
absent or inactive in this cell line. 
In Figure 6B, the transcription complex formed in 
HeLa cells on the same f3-globin promoter is shown. In 
this case, the sph motifs are active. One sph-binding 
factor is shown bound to each sph motif, and together 
the two proteins form an activation domain of the GAL4 
type, able to interact with the TATA box complex. Both 
motifs are shown occupied, because an sph enhanson 
needs to be juxtaposed to a second enhanson to be func- 
tional (Ondek et al. 1988). In this respect, the sph en- 
hansons differ from the B-cell-specific octamer en- 
hanson, which can function autonomously. That the 
TATA box complex is unchanged in Hela cells, as com- 
pared to B cells, is suggested by the observation that the 
~-globin promoter construct containing the UASG is 
stimulated by GAL4 in both HeLa (Fig. 4) and B cells 
(not shown). The different B cell and HeLa cell activities 
of the B element illustrate how a very small element can 
contain two different cell-type-specific a tivities. 
The putative transcription complex formed on the U2 
snRNA promoter is depicted in Figure 6C. Like all RNA 
polymerase II snRNA promoters, the U2 promoter does 
not have a TATA box. Instead, it contains a proximal 
element essential for transcription (for review, see Dahl- 
berg and Lund 1988) located 43-59 bp upstream of the 
cap site (Hemandez and Lucito 1988). The proximal ele- 
ment probably binds a different factor(s) than the TATA 
box, and we refer to this proteinIs) as the snRNA prox- 
imal complex. Activation of the U2 proximal complex 
occurs by a different mechanism than activation of the 
TATA complex of mRNA promoters, because it is not 
stimulated by the SV40 A and C elements, the sph 
motifs, nor the GAL4 trans-activator, all of which stim- 
ulate the ~-globin promoter. The U2 promoter is, how- 
ever, stimulated by the octamer motif, that suggests that 
- -  x - - - ->  - -  x - - - ->  
L I 
B cells 
,~-globin 
[ - - 1  
mx-~y - -x - - -~  
HeLa 
~}-globin 
--x----> - -x- - - - )  
I I 
!i~!~i!ii!!i!!ii!!i~ii~!!~ii~iii!!!i!!ii!!!~i!!!~!i~!ii 
B cells 
+ 
HeLa 
U2 
--x-----) - -  x-----) 
I I 
HeLa 
+ 
VP I6  
,~-globin 
Figure 6. Model for activation of the {3-globin and U2 pro- 
moters by the octamer and sph motifs. Hypothetical complexes 
formed on the 13-globin and U2 promoters in B cells and in HeLa 
cells are shown. The DNA is represented by a thin line, the sph 
motifs are symbolized by arrows, and the octamer motif is indi- 
cated by an open box. For simplicity, only one wild-type B20 
repeat of the synthetic enhancer is shown. (In D, B20 wildtype 
is replaced by B20/dpm2, i.e., there are no functional sph 
motifs.) The start site of transcription is depicted by a wavy 
arrow. The DNA is looped and shown binding a proximal pro- 
moter complex (TATA complex or snRNA proximal complex) 
and a distal trans-activator. Successful protein-protein interac- 
tions between the trans-activator and the proximal complex re- 
sult in an increased rate of transcription i itiation. The oc- 
tamer motif DNA binding domains are stippled and the sph 
motif DNA binding domain is shown striped. The trans-activa- 
tion domains of the GAL4-type trans-activators are shown as 
acidic domains. Oct-1 and Oct-2 are likely candidates for the 
trans-activation factors binding to the octamer motif (for fur- 
ther details, see text). 
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it is the ubiquitous Oct-1 protein which is involved in 
snRNA transcription. 
Although the octamer motif cannot activate the B- 
globin promoter in HeLa cells, coexpression of the HSV 
VP16 protein converts the octamer motif into a mRNA 
promoter-activating element. In Figure 6D, a model of 
the transcription complex formed in HeLa cells in the 
presence of VP16 is shown. Oct-l, normally unable to 
activate the TATA complex of the B-globin promoter, is 
shown bound to the octamer motif and interacting with 
VP16, which in this model converts the Oct-1 protein 
into a GAL4 class trans-activator by providing it with an 
acidic domain. VP16 thus effectively plays the role of an 
adaptor between Oct-1 and the TATA complex. VP16 
indeed contains an acidic domain that is required for 
trans-activation (Triezenberg et al. 1988a), and a hybrid 
protein consisting of the GAL4 DNA binding domain 
fused to the VP16 acidic domain is capable of activating 
a TATA box promoter in which GAL4-binding sites 
have been inserted (Sadowski et al. 1988). In addition, 
the formation i vitro of an octamer binding complex 
containing Oct-l, VP16, and a third, unidentified cel- 
lular protein has recently been demonstrated (Gerster 
and Roeder 1988). Thus, VP16 is an example of a non- 
DNA-binding protein that can switch a promoter from 
an inactive to an active state. 
We were surprised to find that in the presence of 
VP16, the octamer motif activated [3-globin transcrip- 
tion only at a short distance from the promoter, because 
the VP16/GAL4 hybrid protein can activate xpression 
from a distance of -2  kb (Sadowski et al. 1988). This 
position dependence may reflect a property of the oc- 
tamer enhanson which, in contrast o other enhansons 
that function in pairs (Ondek et al. 1988), can function 
without being closely juxtaposed to a second enhanson. 
Indeed, the synthetic enhancer 6 x B2Odpm2, in which 
only the octamer motif is active, was quite sensitive to 
distance in all the constructs and cell lines tested, in- 
cluding the U2 promoter. Alternatively, interaction of 
VP16 with Oct-1 may weaken the affinity of Oct-1 for 
the octamer motif, rendering activation over long dis- 
tances impossible. We have shown previously that Oct-1 
(OBP100) has an affinity, albeit weak, for the TAAT- 
GARAT motif present in the HSV early promoters 
(Baumruker et al. 1988). We suggested that VP16 may 
effectively reprogram the binding specificity of Oct-1 so 
as to secure this cellular transcription factor for HSV 
transcription. In this respect, it will be of interest o de- 
termine whether the TAATGARAT motif can enhance 
expression of the B-globin gene at a distance in the pres- 
ence of VP16. 
The model presented in Figure 6 is consistent with all 
of our data. Whereas the specificity of transcription is
generally thought o be conferred by upstream cis-acting 
elements (for review, see Maniatis et al. 1987; Ptashne 
1988), the model presents the octamer motif as an ex- 
ample where specificity of transcription is conferred by 
the proximal element. In this context, the observation 
that different TATA boxes all respond similarly to in- 
duction mediated through the heat shock element or the 
SV40 enhancer, but fall into two classes-responsive and 
nonresponsive--when tested for E1A activation, sug- 
gests that regulation of expression by proximal elements 
is more general than usually thought (Simon et al. 1988). 
However, if the Oct-1 protein cannot activate the TATA 
complex, how can the octamer motif be involved in 
ubiquitous activation of the histone H2B promoter? In 
this promoter, the octamer motif is uniquely placed ad- 
jacent to the TATA box and confers a cell-cycle-regu- 
lated activation of transcription (LaBella et al. 1988). Be- 
cause there is no evidence that the DNA-binding ac- 
tivity of Oct-1 is cell cycle regulated, it is possible that a 
cell-cycle-regulated factor interacts with the juxtaposed 
Oct-1 and TATA-binding proteins, resulting in periodic 
activation of the promoter. This suggestion implies that 
in the context of the H2B promoter, the close proximity 
of the octamer motif and the TATA box is required for 
its function (see also LaBella et al. 1988). 
The model is also consistent with previous reports 
demonstrating that the U1 enhancer cannot activate 
transcription from the SV40 early promoter (Ciliberto et 
al. 1987; Dahlberg and Schenbom 1988), and with 
studies on the mechanism of U1 and U2 3' end forma- 
tion. These showed that 3' end formation ot only re- 
quires the snRNA 3' box but also signals ocated in the 
5'-flanking sequence of the genes (Hernandez and 
Weiner 1986; Neuman de Vegvar et al. 1986). An exten- 
sive mutagenesis of the U2 promoter egion then dem- 
onstrated that the 5' signals required for 3' end forma- 
tion coincide with promoter elements, suggesting that 
the U2 promoter directs the formation of a specialized 
transcription complex able to recognize the 3' box as a 
termination signal (Hemandez and Lucito 1988). In ad- 
dition, Neuman de Vegvar et al. (1986)have shown that 
when the 3' box of the human U1 gene is debilitated by 
mutations, short RNAs with 3' ends mapping upstream 
of cryptic 3' boxes in the 3'-flanking sequence are gener- 
ated. This suggests that in contrast o the transcription 
complexes formed on mRNA promoters, the transcrip- 
tion complexes formed on snRNA promoters do not 
have the capacity to transcribe through long distances of 
DNA. 
Examination of the different activities of the octamer 
motif reveals that at least one mechanism exists to acti- 
vate polymerase II gene expression that is different from 
the general mechanism involving acidic domains and 
exemplified by the GAL4 protein. Why? The answer 
may lie in the fact that snRNA genes are extremely ac- 
tive transcription units, and the U1 and U2 snRNA 
genes must be transcribed, on average, once every 2 sec 
to account for the synthesis of the complement of 
snRNPs required uring one HeLa cell generation (Ares 
et al. 1985). Thus, the snRNA promoter may use a sepa- 
rate class of transcriptional complex to prevent 
'squelching.' Squelching is a phenomenon of general in- 
hibition of transcription that occurs when a very strong 
GAL4 class activator, such as a hybrid protein con- 
taining the GAL4 DNA-binding domain and the VP16 
acidic domain, is expressed in a cell (Gill and Ptashne 
1988; Sadowski et al. 1988; see also Ptashne 1988). 
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Squelching may occur because the strong activator in- 
teracts with a cellular transcription factor (such as the 
TATA-box-binding factor) independently of DNA 
binding, effectively depleting the cell of a l imit ing tran- 
scription factor (Ptashne 1988). Thus, transcription units 
such as snRNA genes, which are always highly ex- 
pressed in growing cells, may employ their own trans- 
activation mechanism to avoid competi t ion with 
mRNA promoters. Other highly expressed transcription 
units, such as the r ibosomal genes, may have solved this 
problem by using another polymerase (i.e., RNA poly- 
merase I), which may also not respond to the GAL4 type 
of trans-activators. 
Methods  
fl-Globin constructs 
The plasmids pf~e- and pBlx72-  (Ondek et al. 1987), 
pB6 x sphI/sphI + and pf36xsphII/sphII + (Ondek et al. 1988), and 
pBIgh- (Sturm et al. 1987) have been described previously. The 
synthetic enhancers B2Odpm7 and B2Odpm8 were constructed, 
as described previously (Ondek et al. 1988), by self-ligation of 
double-stranded oligonucleotides with complementary 3' over- 
hangs. Fragments containing six copies of the oligonucleotides 
were isolated and inserted into the unique downstream SphI 
site of pBe- (Ondek et al. 1987; see Fig. lc), after emoval of the 
3' overhangs. The resulting constructs had synthetic enhancers 
inserted in the minus orientation, as indicated in Figure 1C, 
except he B2Odpml6 construct, which is in the plus orienta- 
tion. The synthetic enhancers B20 and B2Odpm2 are identical 
to the previously described (Ondek et al. 1988) sphII/sphI and 
sphII/MsphI synthetic enhancers, respectively. In these original 
constructs, however, the synthetic enhancers were in the plus 
orientation and therefore w re inverted to match the other syn- 
thetic enhancer constructs. This was done by excising a PstI- 
HindIII fragment containing the synthetic B20 or B2Odpm2 en- 
hancers and reinserting flush-ended fragments into the SphI- 
cleaved pBe- vector by blunt-end ligation, to give the 
constructs p~6 x B20- and pf36 x B2Odpm2-. The proximal 
p[36xB20+/- 143, p~6xB2Odpm2+/- 143, p~6 x B2Odpm7+/ 
- 143, and pB6 x B2Odpm8 +/- 143 constructs were prepared by 
inserting the PstI-HindIII synthetic enhancer fragments ex- 
cised from original downstream constructs into the SmaI site of 
pBe-, 143 bp upstream of the f3-globin transcriptional start site. 
pBlx72+/-143 was constructed by inserting the 100-bp 
BamHI-PvuII fragment derived from pAO (Zenke t al. 1986) 
into the Sinai site of pf3e-, p[3UASG/- 143 was constructed by 
inserting a filled-in BglII fragment derived from pRY24 {ob- 
tained from M. Ptashne) into the pf~e- SrnaI site. This fragment 
corresponds to the 365-bp Sau3AI-DdeI fragment from the 
GAL1-GALIO promoter region fitted with BglII linkers. 
pBenh- was constructed by digestion of pBe- with SphI, resec- 
tion of the 3' overhangs, and religation (Ondek et al. 1987). 
Some of the constructs have small changes from expected 
structures. These include insertions or deletions up to 2 bp at 
the junction upon cloning and G--~ A transition at the third 
nucleotide of the sphII motif in the first copy of 6 x B2Odpm8 
construct. 
U2 constructs 
pU2/-  198, pU2/-  247, pU26 x A21/- 198, pU26 x C17/-  198, 
pU26 xB17/-198 have been described previously (Hemandez 
and Lucito 1988). pU26xB20/-198, pU26 x B2Odpm2/-198, 
RNA polymerase II trans-activation 
pU26xB20dpm7/-198,  and pU26 x B20dpm8/-198 
were constructed from the pU2/-  247 plasmid (Hernandez and 
Lucito 1988) by replacing the EcoRI-SmaI U2 promoter frag- 
ment extending from -247 to - 198 upstream of the U2 tran- 
scriptional with the synthetic enhancers fragments described 
above. In these constructs, the synthetic enhancers are in the 
plus orientation, relative to the transcriptional direction of the 
U2 promoter, pU2UASG/-198 was constructed by replacing 
the EcoRI-SmaI U2 promoter fragment with the UASc BglII 
fragment described above. 
The plasmids pAG147 and pAG236 were kindly sent by G. 
Toukatly and M. Ptashne and are described in Kakidani and 
Ptashne (1988). The o~-globin plasmids with (~SVHP~2) or 
without (~rSVHSe~2) the SV40 enhancer are described in 
Treisman et al. (1983), and pMSVP16A1D3 was obtained from 
S. McKnight (Triesenberg et al. 1988a). 
Transfections 
NS-1 B cells were transfected by the DEAE-dextran method 
followed by chloroquine treatment, as described (Ondek et al. 
1987), with 4 ~g of the different test plasmids (B-globin and U2 
plasmids) and 0.2 ~g of the ~rSVHPoL2 internal reference 
plasmid. HeLa cells were transfected by the calcium-phos- 
phate coprecipitation procedure, as described (Ondek et 
al. 1987), except hat the precipitates were left on the cells for 
24 hr, and were washed once with phosphate-buffered saline 
(PBS) and once with PBS containing 1 mM EGTA. The cells 
were incubated for an additional 24 hr before harvesting. Two 
micrograms of the B-globin test plasmids were transfected to- 
gether with 0.25 ~g of ~rSVHP~2 (2 ~g of ~rSVHS~2 in Fig. 5), 
and 4 ~g of the U2 test plasmids were transfected together with 
0.1 ~g of ~rSVHPc,2. Where indicated, 4 ~g of pAG147 or 
pAG236, and 2 ~g of pMSVP16A1D3 were included. A total of 
10 ~g of DNA (with pUCll9 as a carrier) was used for a 60-ram 
dish. 
RNA analysis 
Cytoplasmic RNA was prepared from transfected cells by the 
NP-40 lysis method, as described (Hernandez and Lucito 1988), 
and was analyzed by the RNase protection method (Zinn et al. 
1983), with either RNase T1 alone (transfections with U2 test 
plasmids) or with a mixture of RNase A and T1 Itransfections 
with the f3-globin plasmids). The a98 and a132 riboprobes map 
transcripts derived from the a-globin reference gene and are 
protected over 98 and 132 nucleotides, respectively, by cor- 
rectly initiated eeglobin RNA. The f3350 riboprobe maps tran- 
scripts derived from the test B-globin gene and is protected over 
350 nucleotides by correctly initiated B-globin RNA. The U2 A 
probe maps transcripts derived from the hybrid U2 gene and is 
protected over 135 nucleotides by RNA correctly initiated at 
the U2 cap site. The results were quantitated by excising rele- 
vant bands from the gels and measuring their radioactivity by 
scintillation counting or in some cases by densitometric anal- 
ysis of the autoradiograms. 
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Note  added in proof 
Fromental et al. 1988 (Ceil 54: 943-953) recently have discov- 
ered the autonomous B cell-specific enhanson activity of the 
SV40 octamer motif. 
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